Since cancer cells rely heavily on glycolysis and PKM2 is the last rate-limiting enzyme in glycolysis, shikonin, a naturally occurred PKM2 inhibitor, might be able to suppress cancer cell growth by inhibiting the main source of ATP production [4]. This evidence concerns the gene PKM and cancer.